593 results on '"Ferdeghini, M."'
Search Results
2. Nonhyperfunctioning Endocrine Tumors
3. Dual PET/CT with 18F-DOPA and 18F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
4. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
5. Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial
6. Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)
7. Long-term quiescence of ectopic Cushing’s syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: Spontaneous remission or therapeutic effect of bromocriptine?
8. Reply to the Letter to the Editor by Sollini M et al.
9. IMMUNOHISTOCHEMICAL ASSAY OF THE BRAFV600E-MUTATED PROTEIN IN PAPILLARY THYROID CARCINOMA AND COMPARISON WITH SEQUENCING ANALYSIS: OP57
10. RET TRANSLOCATIONS IN PAPILLARY THYROID CARCINOMA DETECTED BY A BREAK-APART INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION ASSAY: OP19
11. Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
12. Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation
13. Lymphokine release during co-culture of human lympho-mononuclear cells and fresh or cultured human, porcine and bovine pancreatic islets
14. Anticlastogenic Effect of Ginkgo Biloba Extract in Graves’ Disease Patients Receiving Radioiodine Therapy
15. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
16. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis
17. Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
18. Solitary Pulmonary Nodule (SPN) and pre-test likelihood of malignancy: the role of FDG-PET/CT in the Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) trial
19. Tumor-associated trypsin inhibitor (TATI) is a good marker of glomerular filtration rate
20. APOB-LIPOPROTEINS APHERESIS: A THERAPY FOR CARDIOVASCULAR DISEASE?
21. Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings
22. 18. Serum concentration of five tumour markers and renal function in man
23. The performance of FDG PET/CT in single pulmonary nodules (SPNs): preliminary analysis from The Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) multicentre trial
24. FDG-PET/CT in single pulmonary nodule (SPN): a preliminary experience from a multicenter Italian Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) trial
25. Restaging Infiltrating Lobular Breast Cancer Patients With Nuclear Medicine
26. FDG PET/CT and breast cancer: Surgery or neoadjuvant CT?
27. Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas
28. UMANIZZAZIONE DELLE CURE IN ETA' PEDIATRICA E ASSISTENZA PSICOLOGICA INTEGRATA IN MEDICINA NUCLEARE
29. Serum CA125 assay at the time of relapse has no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: A multicenter italian study
30. HLA-G polymorphism and papillary thyroid cancer histological aggressiveness
31. HLA-G Polymorphism and Papillary Thyroid Cancer Histological Aggressiveness
32. Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology
33. L’ablazione del residuo tiroideo: indicazioni
34. Impact of the use of Attenuation-Correction in G-SPECT myocardial perfusion imaging interpretation: results of multicenter SPAG (Spect Attenuation-correction vs Gated) study
35. Radioiodine ablation: when and how
36. 18F-DOPA vs. 18F-FDG PET/CT in aggressive metastatic thyroid carcinoma: Preliminary results of a prospective study
37. Effect of Ginkgo biloba extract supplementation on genotoxic damage after thyroid remnant ablation by 131I
38. INCIDENTAL THYROID DISEASE IN AN IODINESUFFICIENT AREA: RESULTS FROM A TELEMEDICINE SURVEY (THE TIMTEM PROJECT)
39. Thyroid function and lipoprotein profile: a cross-sectional study in thyroid disease patients
40. Chromosome translocation frequency after 131I thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged LT4 withdrawal
41. Comparison between remnant and red marrow adsorbed dose in thyroid cancer patients submitted to 131I ablative therapy after r-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawl
42. Codoped Mg1-x(AlLi)xB2 compounds: a key system to probe the effect of charge doping and inter-band scattering
43. Progressively elevated levels of biologically active (free) Cortisol during pregnancy by a direct radioimmunological assay of diffusible Cortisol in an equilibrium dialysis system
44. A Long-Acting Depot Lanreotide in the treatment of patients with Advanced Neuroendocrine Tumors
45. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA and TPS)in patients without evidence of neoplasia
46. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome
47. Tumor markers of epithelial ovarian cancer: Role in diagnosis and therapy
48. IN-111 Octreotide scintigraphy and Tc-99m Sestamibi scintigraphy in metastases of differentiated thyroid carcinoma: comparison with I-131 scan
49. Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma
50. Circulating levels of IGF1 in patients with chronic uremia on conservative dietary treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.